 <h1>Phenytoin Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of phenytoin include:</b> congenital anomalies. <b>Other side effects include:</b> hepatic necrosis, ataxia, confusion, constipation, depression, dizziness, drowsiness, fatigue, hypertrichosis, mental status changes, myasthenia, nervousness, numbness, tremor, tremor of hands, vertigo, excitement, irritability, mood changes, and restlessness.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to phenytoin: oral capsule extended release, oral suspension, oral tablet chewable</i></p><p>Other dosage forms:</p><ul><li>injection solution</li></ul><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, phenytoin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking phenytoin:</p><p>
<i>More common</i>
</p><ul>
<li>Decreased coordination</li>
<li>mental confusion</li>
<li>nervousness</li>
<li>slurred speech</li>
<li>trouble with breathing, speaking, or swallowing</li>
<li>unsteadiness, trembling, or other problems with muscle control or coordination</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Inability to move the eyes</li>
<li>increased blinking or spasms of the eyelid</li>
<li>shakiness and unsteady walk</li>
<li>shakiness in the legs, arms, hands, or feet</li>
<li>sticking out of the tongue</li>
<li>trembling or shaking of the hands or feet</li>
<li>twitching, twisting, or uncontrolled repetitive movements of the tongue, lips, face, arms, or legs</li>
<li>uncontrolled twisting movements of the neck, trunk, arms, or legs</li>
<li>unusual facial expressions</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Bleeding gums</li>
<li>blistering, peeling, or loosening of the skin</li>
<li>blisters, hives, itching, skin rash</li>
<li>bloating of the abdomen or stomach</li>
<li>blood in the urine or stools</li>
<li>bloody, black, or tarry stools</li>
<li>chest pain or discomfort</li>
<li>chills</li>
<li>cough</li>
<li>dark urine</li>
<li>diarrhea</li>
<li>difficulty with moving</li>
<li>fainting spells</li>
<li>fever with or without chills</li>
<li>general feeling of discomfort or illness</li>
<li>general feeling of tiredness or weakness</li>
<li>hair loss</li>
<li>headache</li>
<li>high fever</li>
<li>hoarseness</li>
<li>irritation in the mouth</li>
<li>joint or muscle pain</li>
<li>light-colored stools</li>
<li>lightheadedness or dizziness</li>
<li>lower back or side pain</li>
<li>muscle stiffness</li>
<li>nausea</li>
<li>numbness, tingling, or pain in the hands or feet</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>pinpoint red spots on the skin</li>
<li>red skin lesions, often with a purple center</li>
<li>red, irritated eyes</li>
<li>redness and swelling of the gums</li>
<li>slow or irregular heartbeat</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>stomach pain</li>
<li>swollen, painful, or tender lymph glands in the neck, armpit, or groin</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>upper right abdominal or stomach pain</li>
<li>vomiting</li>
<li>weight loss</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of phenytoin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Trouble sleeping</li>
<li>uncontrolled eye movements</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Difficulty having a bowel movement</li>
<li>enlarged lips</li>
<li>feeling of constant movement of self or surroundings</li>
<li>increased hair growth on the forehead, back, arms, or legs</li>
<li>pain of the penis on erection</li>
<li>sensation of spinning</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to phenytoin: compounding powder, injectable solution, oral capsule, oral capsule extended release, oral suspension, oral tablet chewable</i></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension, vasodilation, tachycardia</p>
<p><b>Uncommon</b> (0.1% to 1%): Shock, cardiac arrest, syncope, cerebral hemorrhage, palpitation, sinus bradycardia, atrial flutter, bundle branch block, cardiomegaly, cerebral infarct, postural hypotension, pulmonary embolus, QT interval prolongation, thrombophlebitis, ventricular extrasystoles, congestive heart failure</p>
<p><b>Frequency not reported</b>: Cardiovascular collapse, severe cardiotoxic reactions with atrial and ventricular conduction depression (including bradycardia and all degrees of heart block), asystole ventricular fibrillation, periarteritis nodosa<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (more serious and rare forms have included bullous, exfoliative or purpuric dermatitis, lupus erythematosus, Stevens-Johnson syndrome and toxic epidermal necrolysis), pruritus</p>
<p><b>Common</b> (1% to 10%): Maculopapular rash, urticaria, sweating, skin discoloration, contact dermatitis, pustular rash, skin nodule, ecchymosis</p>
<p><b>Frequency not reported</b>: Hirsutism, hypertrichosis, coarsening of the facial features, enlargement of the lips, Peyronie's disease.  Dupuytren's contracture and drug rash with eosinophilia and systemic symptoms (DRESS), erythema multiforme, SJS/TEN risk in patients of Asian ancestry who have HLA-B 1502<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Decreased serum T4 and FT4, increased serum estradiol levels, gynecomastia, alterations in vitamin D metabolism<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (13%)</p>
<p><b>Common</b> (1% to 10%): Tongue disorder, dry mouth, vomiting, constipation</p>
<p><b>Uncommon</b> (0.1% to 1%): Dyspepsia, diarrhea, anorexia, GI hemorrhage, increased salivation, tenesmus, tongue edema, dysphagia, flatulence, gastritis, ileus</p>
<p><b>Frequency not reported</b>: Hypoesthesia of the tongue, gingival hyperplasia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Urinary retention, oliguria, dysuria, vaginitis, albuminuria, genital edema, polyuria, urethral pain, urinary incontinence, vaginal moniliasis</p>
<p><b>Frequency not reported</b>: Feeling of warmth or tingling in the groin, Peyronie's disease<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Ecchymosis</p>
<p><b>Uncommon</b> (0.1% to 1%): Thrombocytopenia, anemia, leukocytosis, cyanosis, hypochromic anemia, leukopenia, lymphadenopathy, petechia</p>
<p><b>Frequency not reported</b>: Granulocytopenia, agranulocytosis, pancytopenia (with or without bone marrow suppression), aplastic anemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Liver function tests abnormal, kidney failure</p>
<p><b>Frequency not reported</b>: Toxic hepatitis, hepatocellular damage<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity syndrome, periarteritis nodosa</p>
<p><b>Postmarketing reports</b>: Anaphylactoid reaction, anaphylaxis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Sepsis, flu syndrome, cryptococcosis</p>
<p><b>Frequency not reported</b>: Immunoglobulin abnormalities<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Injection site reaction, injection site pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Injection site inflammation, injection site edema, injection site hemorrhage<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Generalized edema, cachexia, diabetes insipidus</p>
<p><b>Frequency not reported</b>: Hyperglycemia, appetite disorder, hypokalemia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, chills, myasthenia</p>
<p><b>Uncommon</b> (0.1% to 1%): Myopathy, leg cramps, arthralgia, myalgia, muscular weakness, muscle twitching, muscle spasms</p>
<p><b>Frequency not reported</b>: Systemic lupus erythematosus, polyarthritis, Purple Glove Syndrome<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Nystagmus (59%), dizziness (31%), somnolence (27%), ataxia (18%)</p>
<p><b>Common</b> (1% to 10%): Headache, stupor, incoordination, paresthesia, extrapyramidal syndrome, tremor, vertigo, brain edema, tinnitus, taste perversion (including metallic taste), taste loss, reflexes decreased, reflexes increased, migraine, slurred speech, dysarthria, intracranial hypertension, hyperesthesia, hyporeflexia</p>
<p><b>Uncommon</b> (0.1% to 1%): Twitching, Babinski sign positive, circumoral paresthesia, hemiplegia, hypotonia, convulsion, meningitis, CNS depression, hypokinesia, hyperkinesia, brain edema, paralysis, aphasia, coma, myoclonus, acute brain syndrome, encephalitis, subdural hematoma, encephalopathy, akathisia</p>
<p><b>Frequency not reported</b>: CNS depression, dyskinesia (including chorea), dystonia and asterixis similar to those induced by phenothiazines or other neuroleptic drugs, drowsiness, motor twitching, tonic seizures, sensory peripheral polyneuropathy (in patients receiving long-term therapy)<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Diplopia, amblyopia, blurred vision, visual impairment</p>
<p><b>Uncommon</b> (0.1% to 1%): Photosensitivity reaction, photophobia, eye pain, mydriasis, visual field defect<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, deafness, accidental injury, fever, face edema, hyperacusis, parosmia, ear pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Malaise<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Pelvic pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Kidney failure<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pneumonia</p>
<p><b>Uncommon</b> (0.1% to 1%): Pharyngitis, sinusitis, hyperventilation, rhinitis, apnea, aspiration pneumonia, asthma, dyspnea, atelectasis, cough increased, sputum increased, epistaxis, hypoxia, pneumothorax, hemoptysis, bronchitis</p>
<p><b>Postmarketing reports</b>: Respiratory arrest (sometimes fatal)<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Agitation, thinking abnormal, nervousness, depression</p>
<p><b>Uncommon</b> (0.1% to 1%): Confusion, insomnia, depersonalization, psychosis, emotional lability, personality disorder, hostility, amnesia, neurosis, euphoric mood<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p><p id="ref_3">3. "Product Information. Dilantin (phenytoin)." Parke-Davis, Morris Plains, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about phenytoin</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>97 Reviews</li>
<li>Drug class: group I antiarrhythmics</li>
<li>FDA Alerts (3)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Phenytoin injection</li>
<li>Phenytoin &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Phenytoin Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Dilantin, Phenytoin Sodium, Prompt, Phenytek</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +5 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Epilepsy</li>
<li>Cluster-Tic Syndrome</li>
<li>Anxiety</li>
<li>Arrhythmia</li>
<li data-more-config-id="list-data-resources-conditions">... +8 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to phenytoin: compounding powder, injectable solution, oral capsule, oral capsule extended release, oral suspension, oral tablet chewable</i></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension, vasodilation, tachycardia</p><p><b>Uncommon</b> (0.1% to 1%): Shock, cardiac arrest, syncope, cerebral hemorrhage, palpitation, sinus bradycardia, atrial flutter, bundle branch block, cardiomegaly, cerebral infarct, postural hypotension, pulmonary embolus, QT interval prolongation, thrombophlebitis, ventricular extrasystoles, congestive heart failure</p><p><b>Frequency not reported</b>: Cardiovascular collapse, severe cardiotoxic reactions with atrial and ventricular conduction depression (including bradycardia and all degrees of heart block), asystole ventricular fibrillation, periarteritis nodosa<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (more serious and rare forms have included bullous, exfoliative or purpuric dermatitis, lupus erythematosus, Stevens-Johnson syndrome and toxic epidermal necrolysis), pruritus</p><p><b>Common</b> (1% to 10%): Maculopapular rash, urticaria, sweating, skin discoloration, contact dermatitis, pustular rash, skin nodule, ecchymosis</p><p><b>Frequency not reported</b>: Hirsutism, hypertrichosis, coarsening of the facial features, enlargement of the lips, Peyronie's disease.  Dupuytren's contracture and drug rash with eosinophilia and systemic symptoms (DRESS), erythema multiforme, SJS/TEN risk in patients of Asian ancestry who have HLA-B 1502<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Decreased serum T4 and FT4, increased serum estradiol levels, gynecomastia, alterations in vitamin D metabolism<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (13%)</p><p><b>Common</b> (1% to 10%): Tongue disorder, dry mouth, vomiting, constipation</p><p><b>Uncommon</b> (0.1% to 1%): Dyspepsia, diarrhea, anorexia, GI hemorrhage, increased salivation, tenesmus, tongue edema, dysphagia, flatulence, gastritis, ileus</p><p><b>Frequency not reported</b>: Hypoesthesia of the tongue, gingival hyperplasia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Urinary retention, oliguria, dysuria, vaginitis, albuminuria, genital edema, polyuria, urethral pain, urinary incontinence, vaginal moniliasis</p><p><b>Frequency not reported</b>: Feeling of warmth or tingling in the groin, Peyronie's disease<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Ecchymosis</p><p><b>Uncommon</b> (0.1% to 1%): Thrombocytopenia, anemia, leukocytosis, cyanosis, hypochromic anemia, leukopenia, lymphadenopathy, petechia</p><p><b>Frequency not reported</b>: Granulocytopenia, agranulocytosis, pancytopenia (with or without bone marrow suppression), aplastic anemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Liver function tests abnormal, kidney failure</p><p><b>Frequency not reported</b>: Toxic hepatitis, hepatocellular damage<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity syndrome, periarteritis nodosa</p><p><b>Postmarketing reports</b>: Anaphylactoid reaction, anaphylaxis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Sepsis, flu syndrome, cryptococcosis</p><p><b>Frequency not reported</b>: Immunoglobulin abnormalities<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Injection site reaction, injection site pain</p><p><b>Uncommon</b> (0.1% to 1%): Injection site inflammation, injection site edema, injection site hemorrhage<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Generalized edema, cachexia, diabetes insipidus</p><p><b>Frequency not reported</b>: Hyperglycemia, appetite disorder, hypokalemia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, chills, myasthenia</p><p><b>Uncommon</b> (0.1% to 1%): Myopathy, leg cramps, arthralgia, myalgia, muscular weakness, muscle twitching, muscle spasms</p><p><b>Frequency not reported</b>: Systemic lupus erythematosus, polyarthritis, Purple Glove Syndrome<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Nystagmus (59%), dizziness (31%), somnolence (27%), ataxia (18%)</p><p><b>Common</b> (1% to 10%): Headache, stupor, incoordination, paresthesia, extrapyramidal syndrome, tremor, vertigo, brain edema, tinnitus, taste perversion (including metallic taste), taste loss, reflexes decreased, reflexes increased, migraine, slurred speech, dysarthria, intracranial hypertension, hyperesthesia, hyporeflexia</p><p><b>Uncommon</b> (0.1% to 1%): Twitching, Babinski sign positive, circumoral paresthesia, hemiplegia, hypotonia, convulsion, meningitis, CNS depression, hypokinesia, hyperkinesia, brain edema, paralysis, aphasia, coma, myoclonus, acute brain syndrome, encephalitis, subdural hematoma, encephalopathy, akathisia</p><p><b>Frequency not reported</b>: CNS depression, dyskinesia (including chorea), dystonia and asterixis similar to those induced by phenothiazines or other neuroleptic drugs, drowsiness, motor twitching, tonic seizures, sensory peripheral polyneuropathy (in patients receiving long-term therapy)<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Diplopia, amblyopia, blurred vision, visual impairment</p><p><b>Uncommon</b> (0.1% to 1%): Photosensitivity reaction, photophobia, eye pain, mydriasis, visual field defect<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, deafness, accidental injury, fever, face edema, hyperacusis, parosmia, ear pain</p><p><b>Uncommon</b> (0.1% to 1%): Malaise<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Pelvic pain</p><p><b>Uncommon</b> (0.1% to 1%): Kidney failure<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pneumonia</p><p><b>Uncommon</b> (0.1% to 1%): Pharyngitis, sinusitis, hyperventilation, rhinitis, apnea, aspiration pneumonia, asthma, dyspnea, atelectasis, cough increased, sputum increased, epistaxis, hypoxia, pneumothorax, hemoptysis, bronchitis</p><p><b>Postmarketing reports</b>: Respiratory arrest (sometimes fatal)<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Agitation, thinking abnormal, nervousness, depression</p><p><b>Uncommon</b> (0.1% to 1%): Confusion, insomnia, depersonalization, psychosis, emotional lability, personality disorder, hostility, amnesia, neurosis, euphoric mood<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p><p id="ref_3">3. "Product Information. Dilantin (phenytoin)." Parke-Davis, Morris Plains, NJ. </p><h2>More about phenytoin</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>97 Reviews</li>
<li>Drug class: group I antiarrhythmics</li>
<li>FDA Alerts (3)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Phenytoin injection</li>
<li>Phenytoin &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Phenytoin Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +5 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Epilepsy</li>
<li>Cluster-Tic Syndrome</li>
<li>Anxiety</li>
<li>Arrhythmia</li>
<li data-more-config-id="list-data-resources-conditions">... +8 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>